Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection
by
Wang, Xuequan
, Qu, Yuliang
, Liu, Jing
, Zhou, Wenmiao
, Zhang, Zhen
, Zhang, Furui
, Chen, Jiale
, Ni, Linhan
, Guo, Le
, Luo, Xuegang
, Liu, Kunmei
in
Analysis
/ Antibodies
/ Antigens
/ Applied Microbiology
/ Biotechnology
/ Care and treatment
/ Chemistry
/ Chemistry and Materials Science
/ Chronic infection
/ Colonization
/ Complications and side effects
/ Diagnosis
/ Digestive system
/ DNA vaccines
/ Dosage and administration
/ Enzymes
/ Enzymology
/ Gastrointestinal diseases
/ Gastrointestinal system
/ Gastrointestinal tract
/ Genetic Engineering
/ Helicobacter infections
/ Helicobacter pylori
/ Hsp60 protein
/ Immune response
/ Immunogenicity
/ Immunoglobulin G
/ Immunology
/ Infections
/ Investigations
/ Lactic acid bacteria
/ Lactococcus lactis
/ Ligands
/ M cell-targeting
/ M cells
/ Microbial Genetics and Genomics
/ Microbiology
/ Mucosal immune response
/ Mucosal immunity
/ Proteins
/ Proteolysis
/ Proteolytic enzymes
/ Risk factors
/ Urease
/ Vaccine delivery system
/ Vaccines
/ Virulence
/ Virulence (Microbiology)
/ Virulence factors
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection
by
Wang, Xuequan
, Qu, Yuliang
, Liu, Jing
, Zhou, Wenmiao
, Zhang, Zhen
, Zhang, Furui
, Chen, Jiale
, Ni, Linhan
, Guo, Le
, Luo, Xuegang
, Liu, Kunmei
in
Analysis
/ Antibodies
/ Antigens
/ Applied Microbiology
/ Biotechnology
/ Care and treatment
/ Chemistry
/ Chemistry and Materials Science
/ Chronic infection
/ Colonization
/ Complications and side effects
/ Diagnosis
/ Digestive system
/ DNA vaccines
/ Dosage and administration
/ Enzymes
/ Enzymology
/ Gastrointestinal diseases
/ Gastrointestinal system
/ Gastrointestinal tract
/ Genetic Engineering
/ Helicobacter infections
/ Helicobacter pylori
/ Hsp60 protein
/ Immune response
/ Immunogenicity
/ Immunoglobulin G
/ Immunology
/ Infections
/ Investigations
/ Lactic acid bacteria
/ Lactococcus lactis
/ Ligands
/ M cell-targeting
/ M cells
/ Microbial Genetics and Genomics
/ Microbiology
/ Mucosal immune response
/ Mucosal immunity
/ Proteins
/ Proteolysis
/ Proteolytic enzymes
/ Risk factors
/ Urease
/ Vaccine delivery system
/ Vaccines
/ Virulence
/ Virulence (Microbiology)
/ Virulence factors
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection
by
Wang, Xuequan
, Qu, Yuliang
, Liu, Jing
, Zhou, Wenmiao
, Zhang, Zhen
, Zhang, Furui
, Chen, Jiale
, Ni, Linhan
, Guo, Le
, Luo, Xuegang
, Liu, Kunmei
in
Analysis
/ Antibodies
/ Antigens
/ Applied Microbiology
/ Biotechnology
/ Care and treatment
/ Chemistry
/ Chemistry and Materials Science
/ Chronic infection
/ Colonization
/ Complications and side effects
/ Diagnosis
/ Digestive system
/ DNA vaccines
/ Dosage and administration
/ Enzymes
/ Enzymology
/ Gastrointestinal diseases
/ Gastrointestinal system
/ Gastrointestinal tract
/ Genetic Engineering
/ Helicobacter infections
/ Helicobacter pylori
/ Hsp60 protein
/ Immune response
/ Immunogenicity
/ Immunoglobulin G
/ Immunology
/ Infections
/ Investigations
/ Lactic acid bacteria
/ Lactococcus lactis
/ Ligands
/ M cell-targeting
/ M cells
/ Microbial Genetics and Genomics
/ Microbiology
/ Mucosal immune response
/ Mucosal immunity
/ Proteins
/ Proteolysis
/ Proteolytic enzymes
/ Risk factors
/ Urease
/ Vaccine delivery system
/ Vaccines
/ Virulence
/ Virulence (Microbiology)
/ Virulence factors
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection
Journal Article
Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection
2024
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Helicobacter pylori
(
H. pylori
) causes chronic gastric disease. An efficient oral vaccine would be mucosa-targeted and offer defense against colonization of invasive infection in the digestive system. Proteolytic enzymes and acidic environment in the gastrointestinal tract (GT) can, however, reduce the effectiveness of oral vaccinations. For the creation of an edible vaccine,
L. lactis
has been proposed as a means of delivering vaccine antigens.
Results
We developed a plSAM (pNZ8148-SAM) that expresses a multiepitope vaccine antigen SAM-WAE containing Urease, HpaA, HSP60, and NAP extracellularly (named LL-plSAM-WAE) to increase the efficacy of oral vaccinations. We then investigated the immunogenicity of LL-plSAM-WAE in Balb/c mice. Mice that received LL-plSAM-WAE or SAM-WAE with adjuvant showed increased levels of antibodies against
H. pylori
, including IgG and sIgA, and resulted in significant reductions in
H. pylori
colonization. Furthermore, we show that SAM-WAE and LL-plSAM-WAE improved the capacity to target the vaccine to M cells.
Conclusions
These findings suggest that recombinant
L. lactis
could be a promising oral mucosa vaccination for preventing
H. pylori
infection.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
This website uses cookies to ensure you get the best experience on our website.